Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark Levis
Mark Levis
Johns Hopkins University
Cancer research
Medicine
FLT3 Inhibitor
Immunology
Internal medicine
3
Papers
122
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Gilteritinib: potent targeting of FLT3 mutations in AML.
2020
Blood Advances
Mark Levis
Alexander E. Perl
Show All
Source
Cite
Save
Citations (22)
FLT3 inhibitors added to induction therapy induce deeper remissions
2019
Blood
Mark Levis
Wenge Shi
Ken Chang
Christian Laing
Reinhold Pollner
Christopher D. Gocke
Emily Adams
Flora Berisha
Jelveh Lameh
Arnaud Lesegretain
Show All
Source
Cite
Save
Citations (11)
Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL -rearranged ALL cells in a sequence-dependent manner
2006
Leukemia
Patrick A Brown
Mark Levis
Emily McIntyre
Melissa Griesemer
Donald Small
Show All
Source
Cite
Save
Citations (89)
1